APH vs DNTH · P/E 40, rev $23.09B vs rev $6.2M
Amphenol Corporation (APH) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
APH currently screens at market cap $170.77B and trailing P/E 39.9. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the APH and DNTH stock pages for the full models.
Not investment advice.